Tag: VAM 2023
Shockwave L6 catheter achieves ‘almost pristine’ result in challenging case
NOTE: This video is ONLY available to watch in selected countries and geographies
Experts gathered at the Society for Vascular Surgery’s 2023 Vascular Annual...
“Vascular surgery should be a key member of pulmonary embolism response...
“PERT care is the coalition of the willing,” quipped Dennis Gable, a vascular surgeon at Texas Vascular Associates in Plano, USA. He was referring...
Vascular News’ top 10 most popular stories of June 2023
Highlights from this year’s Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2023; 14–17 June, National Harbor, USA) feature prominently in June's top 10.
1. “Sonolysis...
Novel drug candidate for slowing AAA growth demonstrates safety in humans
The local delivery of a glucose-derived compound in small- and medium-sized abdominal aortic aneurysms (AAAs) has been deemed safe, with “promising” early efficacy data...
“Vigilant” surveillance and low threshold for further interventions “crucial” following rescue...
The findings of a recent study on reinterventions and sac dynamics after fenestrated endovascular aneurysm repair (FEVAR) with a physician-modified endograft (PMEG) for index...
BEST-CLI investigators implore a move beyond endo versus open “battle” in...
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J Veith Distinguished Lecture at this year’s Society for...
Endothelial cell granted “superhero” status in invited research presentation at VAM...
“The endothelial cell is the superhero of the vascular system,” Kathryn L Howe (University of Toronto, Toronto, Canada) argued during an invited research presentation...
Two-year DETOUR2 study results presented at VAM 2023
Endologix has announced the 24-month results of the DETOUR2 study, presented at VAM 2023 (14–17 June, National Harbor, USA), the annual meeting of the...
Significant life and limb gains for claudicants who stop smoking before...
Long-term overall survival (OS) and amputation-free survival (AFS) are outcomes that rebound in claudicants who quit smoking prior to elective surgery—and they mirror those...
